drugset / Trial / NCT01417195
Menopur Mixed Protocol
RandomizedParallel-groupOpen-labelTreatment
Summary
The objective of this study was to compare the fertilization rate between the combination of Menopur and Bravelle mixed in the same syringe and Menopur alone, both administered subcutaneously (SC), in subjects undergoing Assisted Reproductive Technology (ART). Additionally the study assessed subjects' ability to mix and store the combination of Menopur and Bravelle and to assess safety of the Menopur and Bravelle combination.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-01
- Completion
- 2012-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bravelle | Unknown | 75 iu | Subcutaneous |
| Subject | Bravelle | Unknown | 150 iu | Subcutaneous |
| Subject | Menopur | Protein / enzyme biologic | 75 iu | Subcutaneous |
| Subject | Menopur | Protein / enzyme biologic | 150 iu | Subcutaneous |
| Subject | Menopur | Protein / enzyme biologic | 225 iu | Subcutaneous |